Invasc Therapeutics -Developing first-in-class drugs for the cardiometabolic market
Invasc Therapeutics -Developing first-in-class drugs for the cardiometabolic market

Oxidative Tissue Damage

There is considerable evidence that oxidative stress is a significant factor in the pathology of diseases such as atherosclerosis, hypertension, kidney disease, cancer, arthritis, diabetes mellitus, Parkinson's disease and stroke. Prolonged and protracted oxidative stress will lead to tissue damage and subsequent impairment to the functioning of our vital organs.

It is important to understand that we need to learn more about oxidative stress and oxidative tissue damage. The increased awareness of oxidative stress related to disease has given rise to a demand for new research and mechanisms of action. Compounds called antioxidants have been shown to have potential benefit in the treatment of diseases. However, these findings are not conclusive. For example, compounds such as vitamin E have antioxidant activity but do not appear to be helpful in the prevention or treatment of cardiovascular disease. InVasc's cofounders are among the world's preeminent scientists in this area and have developed compounds that explore the role of oxidation in treating diseases.

Oxidative tissue damage can impair vital organ functions